Loading clinical trials...
Loading clinical trials...
This is a study during which the investigators collect plasma and cells from patients with myasthenia gravis for the purpose of finding new antibodies.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Johns Hopkins University
NCT06312644 · Ultomiris-exposed Pregnant/ Postpartum, Pregnancy, and more
NCT06754020 · Myasthenia Gravis
NCT07089121 · Childhood-onset Systemic Lupus Erythematous, ANCA-Associated Vasculitis (AAV), and more
NCT07470151 · System Lupus Erythematosus(SLE), Scleroderma, and more
NCT07246564 · Myasthenia Gravis
Johns Hopkins Hospital
Baltimore, Maryland
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions